Bundas24 Bundas24
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Blogs
  • Marketplace
  • Financement
  • Offres
  • Emplois
  • Courses
  • Forums
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • Khushbu Coherent Ajouter une nouvelle offre d'emploi Health
    2025-05-30 08:05:06 -
    Antibody-mediated Rejection Market is driven by Rising Transplants
    Antibody-mediated rejection assays, therapeutics, and monitoring tools have become critical for early detection and treatment of organ rejection events. Products such as complement inhibitors, anti-CD20 monoclonal antibodies, and novel biosensors offer improved graft survival, lower hospital readmission rates, and enhanced patient quality of life. These immunomodulatory therapies and diagnostic...
    0 Commentaires 0 Parts 86 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Khushbu Coherent Ajouter une nouvelle offre d'emploi Health
    2025-06-04 10:38:25 -
    ATTR Amyloidosis Treatment Market is driven by rising market demand
    The ATTR Amyloidosis Treatment Market encompasses therapies designed to address transthyretin (ATTR) amyloidosis, a progressive disorder characterized by abnormal protein deposits in organs and tissues. Core products include RNA interference (RNAi) therapies, monoclonal antibodies, and small-molecule stabilizers that prevent transthyretin misfolding. Advantages of these treatments lie in...
    0 Commentaires 0 Parts 51 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Khushbu Coherent Ajouter une nouvelle offre d'emploi Health
    2025-05-26 09:48:39 -
    Autosomal Dominant Polycystic Kidney Disease Market Is Driven by Novel Therapeutics
    Autosomal dominant polycystic kidney disease (ADPKD) represents one of the most common inherited kidney disorders, characterized by progressive cyst growth that impairs renal function over time. The Autosomal Dominant Polycystic Kidney Disease Market comprises diagnostic tools such as high-resolution imaging and genetic testing kits, along with a growing portfolio of targeted...
    0 Commentaires 0 Parts 84 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Khushbu Coherent Ajouter une nouvelle offre d'emploi Health
    2025-06-05 08:18:41 -
    Glioblastoma Market is driven by Innovative Therapies
    The Global Glioblastoma Market encompasses a broad portfolio of products, including novel immunotherapies, targeted small molecules, advanced radiotherapy equipment, surgical navigation systems, and diagnostic imaging agents designed to improve patient outcomes in aggressive brain tumors. These products offer clear advantages—precision targeting of tumor cells, reduced off-tumor toxicity,...
    0 Commentaires 0 Parts 36 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Khushbu Coherent Ajouter une nouvelle offre d'emploi Health
    2025-06-02 12:57:17 -
    Pheochromocytoma Treatment Market Is Driven by Rising Disease Prevalence
    The Global Pheochromocytoma Treatment Market encompasses a broad spectrum of therapeutic interventions including surgical resection, pharmacological management, and cutting-edge molecular therapies aimed at treating pheochromocytoma, a rare catecholamine-secreting tumor of the adrenal glands. Primary product offerings involve minimally invasive laparoscopic or robotic adrenalectomy,...
    0 Commentaires 0 Parts 121 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Khushbu Coherent Ajouter une nouvelle offre d'emploi Health
    2025-05-27 11:30:04 -
    Pulmonary Hypertension Drugs Market is driven by Rising Disease Prevalence
    Pulmonary hypertension drugs encompass a diverse portfolio of therapeutic agents designed to lower pulmonary arterial pressure, improve right ventricular function and enhance patient quality of life. Key classes include endothelin receptor antagonists (ERAs), phosphodiesterase type 5 (PDE-5) inhibitors, prostacyclin analogs and soluble guanylate cyclase (sGC) stimulators. These products offer...
    0 Commentaires 0 Parts 87 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
© 2025 Bundas24 French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Environ Conditions générale de vente Confidentialité Contactez nous Annuaire